Cancer Centers of the Carolina

Greenville, South Carolina 29615

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Chronic Idiopathic Thrombocytopenic Purpura, Prostate Cancer, Purpura, Thrombocytopenic, Idiopathic

Studies at this site

• A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer — Completed
• Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP) — Completed
• DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2]) — Stopped early